Gynecologic Malignancies in Patients with Diabetes
Melichar B.
Katedra interních oborů Lékařské fakulty UK, Hradec Králové, vedoucí prof. MUDr. J. Malý, CSc., a Klinika onkologie a radioterapie FN, Hradec Králové, přednosta doc. MUDr. J. Petera, Ph.D. |
|
Summary:
Gynecologic malignancies (including breast cancer) represent a substantial proportion of neoplastic
disorders in women. The problems associated with the treatment of gynecologic cancer is
not limited to gynecology and oncology, but involve other specialties, including, in the case of
breast cancer, surgery and radiology. The incidence of gynecologic cancer increases with age,
similarly to other tumors or some internal disorders, including diabetes mellitus. In many patients,
especially elderly, a coincidence of cancer and diabetes mellitus is observed. The presence of
diabetes mellitus, similarly to that of other comorbid conditions, may have a profound impact on
the prognosis and the choice of treatment for the individual patient. Moreover, some studies
indicate that diabetes mellitus increases the risk of breast and endometrial carcinoma. As in
other areas of medicine, a close collaboration between specialists treating the tumor (surgeon or
gynecologist, medical and radiation oncologist) with physicians specialized in treating comorbid
conditions (internal medicine, cardiology or diabetes medicine) is inevitable. The current state of
the treatment of gynecologic cancer is reviewed, with a special focus on breast cancer. The progress
in breast cancer treatment illustrates how the understanding of molecular mechanisms
underlying tumor growth and evidence-based medicine can lead to a major improvement of the
prognosis of cancer.
Key words:
Breast cancer - Diabetes mellitus - Gynecologic cancers - Treatment
|